Cleaved caspase 3 activity was qualitatively and quantitatively elevated in mice treated with relacorilant + paclitaxel compared to paclitaxel alone, while no difference was observed for CK18 (a tumor cell marker) and Ki67 (a proliferation marker) (Figure 4E and 4F). Here, KRT18 is linked to neoplasm.